Nutrimed
ActiveNutrimed has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.62M and a net result of €630k. Equity is growing by ~49.4% per year across the filed fiscal years. Its solvency ranks better than 95% of 794 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
93
/ 100
Excellent▼ -7 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability87▼-13
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €340k at 30 days acceptable
Liquidity ample (current ratio 64.3 against 28.74 in 2024), and 7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 10
Relative position
BE, all sectors
reference
Sector 10
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
93%
Return on assets
16.2%
Age of the figures
12 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 16-03-2026, 45 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
45 d early
2024
44 d early
2023
53 d early
2022
44 d early
2021
47 d early
2020
44 d early
2019
38 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€3.62M▲ 21.1%
2024 · €2.99M
2018: €106k
2019: €95k
2020: €295k
2021: €879k
2022: €1.59M
2023: €2.26M
2024: €2.99M
2018 → 2025
Total assets
€3.89M▲ 16.8%
2024 · €3.33M
2018: €426k
2019: €497k
2020: €871k
2021: €1.26M
2022: €2.05M
2023: €2.64M
2024: €3.33M
2018 → 2025
Net result
€630k▼ 13.3%
2024 · €727k
2018: €264k
2019: €339k
2020: €365k
2021: €584k
2022: €707k
2023: €677k
2024: €727k
2018 → 2025
Working capital
€3.55M▲ 21.6%
2024 · €2.92M
2018: €106k
2019: €94k
2020: €239k
2021: €813k
2022: €1.51M
2023: €2.19M
2024: €2.92M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€879k-€1.59M▲ 80.3%€2.26M▲ 42.7%€2.99M▲ 32.1%€3.62M▲ 21.1%
Operating result€783k-€1.04M▲ 33.5%€999k▼ 4.4%€1.00M▲ 0.3%€870k▼ 13.2%
Net result€584k-€707k▲ 21.0%€677k▼ 4.1%€727k▲ 7.4%€630k▼ 13.3%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 13% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.89M
Fixed assets
€287k▼ 7.3%
Current assets
€3.61M▲ 19.2%
Equity and liabilities €3.89M
Equity
€3.62M▲ 21.1%
Debt
€271k▼ 20.9%
The debt ratio falls from 10.3% to 7.0%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€893k▼
2024 · €1.02M
Cash flow
€653k▼
2024 · €750k
Solvency
93.0%▲
2024 · 89.7%
Current ratio
64.30▲
2024 · 28.74
Quick ratio
56.51▲
2024 · 23.08
Debt / equity
0.07▼
2024 · 0.11
ROE
17.4%▼
2024 · 24.3%
ROA
16.2%▼
2024 · 21.8%
Interest coverage
131.79▼
2024 · 154.52
Debt
€271k▼
2024 · €343k
Debt ≤ 1 year
€56k▼
2024 · €105k
Debt > 1 year
€215k▼
2024 · €237k
Income taxes
€290k▼
2024 · €336k
Staff costs
€69k▲
2024 · €68k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€3.33M€3.89M▲
Fixed assets21/28€309k€287k▼
Tangible fixed assets22/27€309k€287k▼
Land and buildings22€303k€284k▼
Plant, machinery and equipment23€6k€3k▼
Furniture and vehicles24€731€268▼
Current assets29/58€3.02M€3.61M▲
Stocks and contracts in progress3€596k€437k▼
Stocks30/36€596k€437k▼
Amounts receivable within one year40/41€167k€157k▼
Trade receivables40€166k€154k▼
Other amounts receivable41€2k€3k▲
Current investments50/53€2.12M€2.65M▲
Cash at bank and in hand54/58€137k€354k▲
Deferred charges and accrued income490/1€790€5k▲
Equity and liabilities
Total equity and liabilities10/49€3.33M€3.89M▲
Equity10/15€2.99M€3.62M▲
Contributions10/11€50k€50k=
Reserves13€2.94M€3.57M▲
Distributable reserves133€2.94M€3.57M▲
Amounts payable17/49€343k€271k▼
Amounts payable after more than one year17€237k€215k▼
Financial debts170/4€237k€215k▼
Amounts payable within one year42/48€105k€56k▼
Current portion of amounts payable after more than one year42€22k€22k▲
Trade debts44€58k€18k▼
Suppliers440/4€58k€18k▼
Taxes, remuneration and social security45€23k€12k▼
Taxes450/3€16k€4k▼
Remuneration and social security454/9€8k€8k▲
Other amounts payable47/48€2k€4k▲
Income statement
Code20242025
Remuneration, social security and pensions62€68k€69k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€23k€23k=
Other operating charges640/8€4k€4k▲
Gross operating margin9900€1.10M€966k▼
Operating profit (loss)9901€1.00M€870k▼
Financial income75/76B€68k€57k▼
Recurring financial income75€68k€57k▼
Financial charges65/66B€7k€7k▲
Recurring financial charges65€7k€7k▲
Profit (loss) for the period before taxes9903€1.06M€920k▼
Income taxes67/77€336k€290k▼
Profit (loss) for the period9904€727k€630k▼
Profit (loss) for the period to be appropriated9905€727k€630k▼
Appropriation of the result
Profit (loss) to be appropriated9906€727k€630k▼
Transfer to equity691/2€727k€630k▼
To other reserves6921€727k€630k▼
Social balance
Average headcount (FTE)90871.81.8=
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
16-03
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
30-09
Financial
Liquidity doublescurrent ratio 64.30
Current ratio from 28.74 to 64.30; short-term debt falls from €105k to €56k.
17-03
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
30-09
Financial
Highest result since 2018net €727k ▲7.4%
Net result €727k, the highest in the series.
08-03
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-09
Financial
Liquidity doublescurrent ratio 20.06
Current ratio from 9.49 to 20.06; short-term debt falls from €178k to €115k.
30-09
Financial
Equity above €2MEq €2.26M ▲42.7%
6 profitable years in a row build equity to €2.26M.
17-03
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-09
Financial
Equity above €1MEq €1.59M ▲80.3%
5 profitable years in a row build equity to €1.59M.
14-03
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-09
Financial
Liquidity times 6current ratio 11.22
Current ratio from 1.95 to 11.22; short-term debt falls from €252k to €80k.
30-09
Financial
Equity above €500kEq €879k ▲198%
4 profitable years in a row build equity to €879k.
17-03
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-09
Financial
Equity above €200kEq €295k ▲210%
3 profitable years in a row build equity to €295k.
23-03
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
26-03
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
27-04
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
28-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Dendermonde · 2 establishment units since 2009
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Achthoek (STG) 309200 DendermondeGround area
1,646 m²
Building footprint
640 m²
Volume, LiDAR
6,773 m³
2 parcels, Flanders · tallest building 16.2 m, ±4 floors. Linked by address, not a title deed.
2 establishment units
Achthoek (STG) 30, 9200 Dendermonde
since 20092.183.411.206
Nutrimed
since 20212.316.343.271
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 42021C0146/00B002 | Flanders | 985 m² | 1 · 502 m² | 16.1 m · 4 fl. |
| 42021C0179/00E002 | Flanders | 661 m² | 1 · 138 m² | 8.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
2 sitesDendermonde2.183.411.206
Dendermonde2.316.343.271
Similar companies · same sector, comparable size
Be-Life
BE 0444.733.518
Gembloux · Eq €3.40M
MEDIX Laboratoires
BE 0543.388.753
Oudenaarde · Eq €4.16M
PHARMA MANUFACTURING
BE 0475.313.955
Gembloux · Eq €2.75M
METAROM BENELUX
BE 0405.669.044
Vorst · Eq €4.77M
Nestlé Belgilux
BE 0402.231.383
Anderlecht · Eq €4.93M
Of 87 companies in sector 10860 we hold annual accounts for 47. 16 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded07-12-2009
Fiscal year end30-09
Activities, NACEBEL
10860Manufacture of food products
46389Wholesale of other food products
46150Agents in the wholesale of furniture, household goods and hardware
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:0474/99 05 72